Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based

S Masiha1, J Sundström, L Lind

  • 1Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden. said.masiha@medsci.uu.se

Insights

Inflammatory markers like hsCRP and E-selectin are elevated in elderly individuals with abnormal left ventricular (LV) geometry, particularly concentric LVH. These markers also correlate with impaired LV diastolic function.

Area of Science:

  • Cardiology
  • Gerontology
  • Immunology

Background:

  • Inflammation is linked to left ventricular hypertrophy (LVH) in specific patient groups.
  • Understanding inflammation's role in cardiac structure and function in the elderly is crucial.

Purpose of the Study:

  • To investigate the relationship between circulating inflammatory markers and left ventricular (LV) geometry and diastolic function in an elderly population.
  • To identify specific inflammatory markers associated with different LV geometric patterns and diastolic dysfunction.

Main Methods:

  • Utilized data from the Prospective Study of the Vasculature in Uppsala Seniors (PIVUS) cohort (n=1016, age 70).
  • Echocardiography assessed LV geometry (RWT, LVMI) and diastolic function (E/A-ratio), defining four geometric subgroups.
  • Measured 10 circulating inflammatory markers, including hsCRP, E-selectin, ICAM-1, VCAM-1, and P-selectin.

Main Results:

  • Elevated levels of high-sensitivity C-reactive protein (hsCRP) and E-selectin were observed in individuals with abnormal LV geometry compared to normal geometry.
  • Specific adhesion molecules (ICAM-1, VCAM-1, P-selectin) and hsCRP were significantly higher in the concentric LVH group.
  • hsCRP and l-selectin showed a correlation with the E/A-ratio, indicating a link to diastolic dysfunction.

Conclusions:

  • Inflammatory markers, particularly adhesion molecules and hsCRP, are elevated in elderly individuals with abnormal LV geometry, especially concentric LVH.
  • These findings suggest a potential role for inflammation in the development of abnormal LV geometry and diastolic dysfunction in older adults.
  • Further research is warranted to explore the pathogenic mechanisms linking inflammation to cardiac remodeling and function.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...